US medicine recalled by Sun Pharma and Lupin due to production problems

18 Dec 2023 , 11:37 AM

Top pharmaceutical companies, Sun Pharma and Lupin have recalled their medicines due to production problems in the US market according to the USFDA. 

In order to address underactive thyroid syndrome, Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of lithyronine sodium tablets in the US. According to the USFDA, the manufacturer is recalling the lot because it ‘failed impurities/degradation specifications’.

The company’s unit, Princeton-based Sun Pharmaceutical Industries Inc., is recalling the impacted batch, which was manufactured at the Dadra factory.

On December 4 of this year, Sun Pharma initiated a voluntary countrywide Class II recall.

The US Food and Drug Administration announced that a certain quantity of penicillamine pills manufactured by Mumbai-based Lupin are likewise being recalled in the US.

Wilson’s disease and rheumatoid arthritis are the conditions that the drug is used to treat. The company’s unit, Baltimore-based Lupin Pharmaceuticals Inc., is recalling the impacted batch, which was manufactured in the pharmaceutical company’s Nagpur plant.

‘Failed dissolution specifications’ are the reason the corporation is recalling the affected lot, according to the USFDA.

On November 22, the business started the voluntary Class II nationwide recall in the United States.

According to the USFDA, a class II recall is started when there is a remote possibility of substantial adverse health effects or when using or being exposed to a violative product may result in short-term or medically reversible adverse health effects.

For feedback and suggestions, write to us at [e-mail]